Author:
Hirst Jennifer A.,McLellan Julie H.,Price Christopher P.,English Emma,Feakins Benjamin G.,Stevens Richard J.,Farmer Andrew J.
Abstract
AbstractBackground:Point-of-care (POC) devices could be used to measure hemoglobin AMethods:Medline, Embase and Web of Science databases were searched in June 2015 for published reports comparing POC HbAResults:Two researchers independently reviewed 1739 records for eligibility. Sixty-one studies were included in the meta-analysis of mean bias. Devices evaluated were A1cgear, A1cNow, Afinion, B-analyst, Clover, Cobas b101, DCA 2000/Vantage, HemoCue, Innovastar, Nycocard, Quo-Lab, Quo-Test and SDA1cCare. Nine devices had a negative mean bias which was significant for three devices. There was substantial variability in bias within devices. There was no difference in bias between clinical or laboratory operators in two devices.Conclusions:This is the first meta-analysis to directly compare performance of POC HbA
Subject
Biochemistry, medical,Clinical Biochemistry,General Medicine
Reference158 articles.
1. [Diagnostic agreement between two glycosylated a1b hemoglobin methods in Primary Care];Semergen,2014
2. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression;Stata J,2009
3. Point-of-care testing of HbA1C is traceable to IFCC reference method by external calibration;Clin Chim Acta,2014
4. Multi-site correlation of A1cNow %A1C assay to a standardized laboratory;Clin Chem,2005
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献